Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Feb 01
|
Sell
|
66.77 |
11,860 |
791,892 |
|
02/05/24 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Feb 01
|
Sell
|
67.06 |
33,885 |
2,272,328 |
1,050,309 |
02/05/24 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Feb 01
|
Sell
|
67.08 |
11,860 |
795,569 |
29,700 |
02/05/24 |
Hineline Lawrence J. |
SVP of Finance, CFO
SVP of Finance, CFO
|
Feb 01
|
Sell
|
66.98 |
11,183 |
749,037 |
|
02/05/24 |
Durgam Suresh K. |
EVP, Chief Medical O..
EVP, Chief Medical Officer
|
Feb 01
|
Sell
|
67.09 |
6,167 |
413,744 |
5,693 |
02/05/24 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Jan 16
|
Sell
|
66.5 |
191,362 |
12,725,573 |
1,050,309 |
01/18/24 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Jan 16
|
Option
|
16.86 |
191,362 |
3,226,363 |
1,118,226 |
01/18/24 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Jan 11
|
Sell
|
67.07 |
50,000 |
3,353,500 |
|
01/12/24 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Jan 11
|
Option
|
18.34 |
50,000 |
917,000 |
50,000 |
01/12/24 |
Durgam Suresh K. |
EVP, Chief Medical O..
EVP, Chief Medical Officer
|
Jan 02
|
Sell
|
70.99 |
62,282 |
4,421,399 |
|
01/04/24 |
Durgam Suresh K. |
EVP, Chief Medical O..
EVP, Chief Medical Officer
|
Jan 02
|
Option
|
19.87 |
62,282 |
1,237,543 |
62,282 |
01/04/24 |
Durgam Suresh K. |
EVP, Chief Medical O..
EVP, Chief Medical Officer
|
Dec 13
|
Sell
|
65.00 |
21,262 |
1,382,030 |
|
12/15/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Nov 06
|
Sell
|
55.5 |
42,393 |
2,352,812 |
29,700 |
11/08/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Nov 06
|
Option
|
23.94 |
26,754 |
640,491 |
72,093 |
11/08/23 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Sep 18
|
Sell
|
53.89 |
100,000 |
5,389,000 |
1,050,309 |
09/19/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Aug 07
|
Sell
|
58.79 |
55,300 |
3,251,087 |
45,339 |
08/09/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Aug 07
|
Option
|
18.59 |
55,300 |
1,028,027 |
100,639 |
08/09/23 |
Durgam Suresh K. |
EVP, Chief Medical O..
EVP, Chief Medical Officer
|
Jul 17
|
Sell
|
65.00 |
1,842 |
119,730 |
21,262 |
07/20/23 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Jun 14
|
Sell
|
64.24 |
81,854 |
5,258,301 |
|
06/16/23 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Jun 14
|
Option
|
42.8 |
81,854 |
3,503,351 |
81,854 |
06/16/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Mar 28
|
Sell
|
54.44 |
15,604 |
849,482 |
45,339 |
03/30/23 |
Durgam Suresh K. |
EVP, Chief Medical O..
EVP, Chief Medical Officer
|
Mar 10
|
Sell
|
44.69 |
7,344 |
328,203 |
23,104 |
03/13/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Mar 09
|
Sell
|
43.85 |
12,308 |
539,706 |
60,943 |
03/13/23 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Mar 09
|
Sell
|
43.72 |
24,052 |
1,051,553 |
|
03/13/23 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Mar 09
|
Sell
|
43.7 |
21,245 |
928,407 |
|
03/13/23 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Mar 09
|
Sell
|
43.73 |
62,335 |
2,725,910 |
1,130,309 |
03/13/23 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Mar 09
|
Option
|
3.26 |
20,000 |
65,200 |
1,150,309 |
03/13/23 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Feb 18
|
Sell
|
47.62 |
3,898 |
185,623 |
52,580 |
02/22/23 |
Durgam Suresh K. |
SVP, Chief Medical O..
SVP, Chief Medical Officer
|
Feb 18
|
Sell
|
48 |
8,354 |
400,992 |
23,104 |
02/22/23 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Feb 18
|
Sell
|
48.02 |
11,139 |
534,895 |
|
02/22/23 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Feb 18
|
Sell
|
48.76 |
64,411 |
3,140,680 |
|
02/22/23 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Feb 18
|
Option
|
12.73 |
53,968 |
687,013 |
53,968 |
02/22/23 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Feb 18
|
Sell
|
48.05 |
27,848 |
1,338,096 |
1,100,309 |
02/22/23 |
Mates Sharon |
Chairman, President..
Chairman, President & CEO
|
Dec 13
|
Sell
|
55.00 |
33,083 |
1,819,565 |
1,100,309 |
12/15/22 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Dec 01
|
Option
|
15.47 |
50,000 |
773,500 |
50,000 |
12/02/22 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Dec 01
|
Sell
|
53.71 |
50,000 |
2,685,500 |
|
12/02/22 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Sep 21
|
Option
|
15.47 |
65,164 |
1,008,087 |
65,164 |
09/23/22 |
Hineline Lawrence J. |
SVP of Finance CFO
SVP of Finance CFO
|
Sep 21
|
Sell
|
45.64 |
65,164 |
2,974,085 |
|
09/23/22 |
VAN NOSTRAND ROBERT L |
Director
Director
|
Aug 11
|
Option
|
12.75 |
30,000 |
382,500 |
39,043 |
08/12/22 |
VAN NOSTRAND ROBERT L |
Director
Director
|
Aug 11
|
Sell
|
56.98 |
30,000 |
1,709,400 |
9,043 |
08/12/22 |
MARCUS JOEL S |
Director
Director
|
Aug 11
|
Sell
|
59.22 |
10,000 |
592,200 |
44,233 |
08/12/22 |
MARCUS JOEL S |
Director
Director
|
Jun 18
|
Sell
|
55 |
10,000 |
550,000 |
54,233 |
05/13/22 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Apr 08
|
Option
|
12.73 |
86,348 |
1,099,210 |
131,687 |
04/08/22 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Apr 08
|
Sell
|
64.37 |
86,348 |
5,558,221 |
45,339 |
04/08/22 |
RIGGS RORY B |
Director
Director
|
Mar 16
|
Sell
|
60.1 |
226,670 |
13,622,867 |
|
03/18/22 |
MARCUS JOEL S |
Director
Director
|
Mar 07
|
Sell
|
53.22 |
20,000 |
1,064,400 |
28,980 |
03/09/22 |
Durgam Suresh K. |
Chief Medical Office..
Chief Medical Officer
|
Mar 02
|
Sell
|
56.25 |
8,037 |
452,081 |
23,104 |
03/04/22 |
Durgam Suresh K. |
Chief Medical Office..
Chief Medical Officer
|
Feb 23
|
Sell
|
52.17 |
4,046 |
211,080 |
31,141 |
02/25/22 |
Neumann Mark |
EVP, Chief Commercia..
EVP, Chief Commercial Officer
|
Feb 23
|
Sell
|
52.1 |
7,906 |
411,903 |
45,339 |
02/25/22 |
Halstead Michael |
EVP and General Coun..
EVP and General Counsel
|
Feb 23
|
Sell
|
52 |
7,906 |
411,112 |
|
02/25/22 |